Skip to main content

Table 2 iBAT mass, triacylglyerol and protein content

From: Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti-obesogenic effects in mice

Mass

C

HF

HF/n-3

iBAT (mg)

179.3

±

21.2

312

±

15.5a

246.8

±

18.2a, b

Subgroup (n = 5)

 TAG (mg)/g iBAT

92.6

±

9.3

118.1

±

13.7

118.4

±

12.7

 TAG (mg) in total iBAT

20.7

±

1.6

40.7

±

6.9a

32.1

±

5.6

 Protein (mg)/g iBAT

49.2

±

3.6

37.0

±

1.3a

45.4

±

2.0

 Protein (mg) in total iBAT

11.2

±

1.1

12.5

±

0.7

11.9

±

1.2

 TAG (mg)/protein (mg)

1.9

±

0.1

3.3

±

0.5a

2.6

±

0.2

  1. All data are means ± SEM and were collected from mice after 12-week feeding either control (C), HFD (HF), or n-3 long-chain polyunsaturated fatty acid (LCPUFA)-enriched HFD (HF/n-3). Index letters a and b indicate a significant difference (p < 0.05) compared to C and HF group, respectively
  2. iBAT interscapular brown adipose tissue, TAG triacylglycerol